%D8%B9%D9%84%D8%A7%D8%AC_%D9%85%D9%86%D8%A7%D8%B9%D9%8A%D0%98%D0%BC%D1%83%D0%BD%D0%BE%D1%82%D0%B5%D1%80%D0%B0%D0%BF%D0%B8%D1%8FImmunoter%C3%A0piaImunoterapieImmuntherapie%CE%91%CE%BD%CE%BF%CF%83%CE%BF%CE%B8%CE%B5%CF%81%CE%B1%CF%80%CE%B5%CE%AF%CE%B1ImmunotherapyInmunoterapiaImmunoteraapiaImmunoterapia%D8%A7%DB%8C%D9%85%D9%86%DB%8C%E2%80%8C%D8%AF%D8%B1%D9%85%D8%A7%D9%86%DB%8CImmunoterapiaImmunoth%C3%A9rapieInmunoterapia%D7%90%D7%99%D7%9E%D7%95%D7%A0%D7%95%D7%AA%D7%A8%D7%A4%D7%99%D7%94Immunter%C3%A1piaImunoterapiImmunoterapia%E5%85%8D%E7%96%AB%E7%99%82%E6%B3%95%D0%98%D0%BC%D0%BC%D1%83%D0%BD%D0%BE%D1%82%D0%B5%D1%80%D0%B0%D0%BF%D0%B8%D1%8F%EB%A9%B4%EC%97%AD%EC%9A%94%EB%B2%95ImmunotherapieImmunoterapiaImunoterapiaImunoterapie%D0%98%D0%BC%D0%BC%D1%83%D0%BD%D0%BE%D1%82%D0%B5%D1%80%D0%B0%D0%BF%D0%B8%D1%8FImmunterapi%E0%AE%A8%E0%AF%8B%E0%AE%AF%E0%AF%86%E0%AE%A4%E0%AE%BF%E0%AE%B0%E0%AF%8D%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AE%BF%E0%AE%AF%E0%AE%9A%E0%AF%8D_%E0%AE%9A%E0%AE%BF%E0%AE%95%E0%AE%BF%E0%AE%9A%E0%AF%8D%E0%AE%9A%E0%AF%88%D0%86%D0%BC%D1%83%D0%BD%D0%BE%D1%82%D0%B5%D1%80%D0%B0%D0%BF%D1%96%D1%8F%D9%85%D8%B9%D8%A7%D9%84%D8%AC%DB%82_%D9%85%D9%86%D8%A7%D8%B9%DB%8C%DB%81ImmunoterapiyaQ1427096%E5%85%8D%E7%96%AB%E6%B2%BB%E7%96%97
about
P2868
Adoptive immunotherapy of cytokine-induced killer cell therapy in the treatment of non-small cell lung cancerHarnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell TypesNatural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodiesEpicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized miceIntact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in miceOral and sublingual immunotherapy for food allergymiR-17-92 expression in differentiated T cells - implications for cancer immunotherapyPhase IIb randomized trial of adjunct immunotherapy in patients with first-diagnosed tuberculosis, relapsed and multi-drug-resistant (MDR) TBInvariant NKT cells as novel targets for immunotherapy in solid tumorsInterferon lambda: a new sword in cancer immunotherapyCombination of a novel oncolytic immunotherapeutic agent, CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma modelImmunotherapy as treatment for Alzheimer’s diseasePractice parameter: Immunotherapy for Guillain-Barre syndrome: Report of the Quality Standards Subcommittee of the American Academy of NeurologyImmunotherapy for Guillain-Barre syndrome: a systematic reviewImmunotherapy: past, present and futureTargeting Tumor-Related Immunosuppression for Cancer ImmunotherapyThe immunotherapeutic potential of melatoninImmunotherapy for the Adjunctive Treatment of Sepsis: From Immunosuppression to Immunostimulation. Time for a Paradigm Change?Recognition of live phosphatidylserine-labeled tumor cells by dendritic cells: a novel approach to immunotherapy of skin cancerSpecific allergen immunotherapy for the treatment of atopic eczemaImmunotherapy for metastatic renal cell carcinomaInterventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapyImmunotherapy for advanced renal cell cancerSublingual immunotherapy for asthmaLocal nasal immunotherapy for allergic rhinitisImmunotherapy (oral and sublingual) for food allergy to fruitsOral and sublingual immunotherapy for egg allergyImmunotherapy for recurrent miscarriageAntigen-specific active immunotherapy for ovarian cancerImmunotherapy for stage I-III non-small cell lung cancer treated with surgery or radiotherapy with curative intentSublingual immunotherapy for asthmaImmunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathiesVenom immunotherapy for preventing allergic reactions to insect stingsAllergen-specific oral immunotherapy for peanut allergyInterventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapyImmunotherapy for idiopathic lumbosacral plexopathyOral and sublingual immunotherapy for egg allergyInterventions for the treatment of oral and oropharyngeal cancers: immunotherapy/biotherapyImmunotherapy for diabetic amyotrophyOral immunotherapy for milk allergy
P921
description
Phương pháp trị liệu bằng cách gây ra hoặc khuếch đại phản ứng miễn dịch
@vi
geneeskundige therapie gericht op het afweersysteem
@nl
therapy to elicit or amplify an immune response
@en
tratamiento para estimular o reponer el sistema inmunitario
@es
θεραπεία μιας ασθένειας για τη ...... του οργανισμού σε αλλεργιογόνα
@el
用於引發或放大免疫反應的療法
@zh
name
Immunoteraapia
@et
Immunoterapia
@eu
Immunoterapia
@pl
Immunoterapiya
@uz
Immunotherapy
@en-ca
Immunotherapy
@en-gb
Immuntherapie
@de
Imunoterapi
@id
Imunoterapia
@pt-br
Imunoterapie
@ro
type
label
Immunoteraapia
@et
Immunoterapia
@eu
Immunoterapia
@pl
Immunoterapiya
@uz
Immunotherapy
@en-ca
Immunotherapy
@en-gb
Immuntherapie
@de
Imunoterapi
@id
Imunoterapia
@pt-br
Imunoterapie
@ro
altLabel
Immunomodulation therapy
@en
Immunoterapia nowotworów
@pl
Imunoterapia
@ro
Terapias biológicas
@es
Wikipedia:WikiProiect Articole de creat/Imunoterapia
@ro
bioterapia
@es
cílená léčba
@cs
immunoterapi
@nb
immunoterapi
@sv
immuuniterapia
@fi
prefLabel
Immunoteraapia
@et
Immunoterapia
@eu
Immunoterapia
@pl
Immunoterapiya
@uz
Immunotherapy
@en-ca
Immunotherapy
@en-gb
Immuntherapie
@de
Imunoterapi
@id
Imunoterapia
@pt-br
Imunoterapie
@ro
P349
P486
P6366
P646
P672
P1051
P1245
P1296
P1417
topic/immunotherapy
P279
P2924
P3219
cancer-immunotherapie
P3417
Immunotherapy
P3471
P349
P373
Immunotherapy
P3827
biological-therapy
immunotherapy
P4613
P486
P6366
2777097442
2777701055
P646
P672
E02.095.465.425